LSD Therapy for Persons Suffering From Major Depression: A Randomised, Double-blind, Active-placebo Controlled Phase II Study
Latest Information Update: 25 Apr 2025
At a glance
- Drugs Lysergide (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 14 Apr 2023 Primary endpoint (Change in depressive symptomatology assessed by questionnaire compared with active placebo) has been met, according to a Mindmed media release.
- 14 Apr 2023 According to Mindmed media release, Prof. Matthias Liechti, is the co-primary investigator of the trial.
- 14 Apr 2023 Results presented in the Mindmed media release.